Give Merck a Break...

I'm starting to feel sorry for Merck. They just lost a patent dispute with their Fosamax drug. The patent will now expire in 2008 instead of 2018, that hurts big time. Just when you thought things couldn't get any worse, it does. Fortunately, I don't have any Merck.

Not really surprising that the market is in the gloom and doom mood today. Lots of potential market moving news over the weekend. The elections in Iraq, etc... I guess a lot of people want to enter the weekend flat.

I'm starting to take a closer look at Amgen's numbers. Their 0.02 miss wasn't that bad. The top line number was fine, but their expenses increased more than expected. They are also buying backing back a bunch of stock. There's a lot of uncertainty for Amgen in 2005, but this is where you do your research and look beyond 2005. I may add to my Amgen position.